erlotinib hydrochloride has been researched along with Chronic Kidney Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda-Hihara, K; Iseri, K; Iyoda, M; Matsumoto, K; Saito, T; Shibata, T; Suzuki, T; Tachibana, S; Wada, Y; Yamamoto, Y | 1 |
| Borza, C; Chen, JC; Fan, X; Fogo, AB; Harris, RC; Jin, GN; Li, Y; Li, Z; Niu, A; Pan, Y; Pozzi, A; Sasaki, K; Wang, S; Wang, Y; Yang, H; Zhang, MZ | 1 |
| Cosmai, L; Gallieni, M; Porta, C | 1 |
| Alvarez-Hernandez, D; Arcidiacono, MV; Cannata-Andia, J; Dusso, AS; Gonzalez-Suarez, I; Lu, Y; Sato, T; Slatopolsky, E; Tokumoto, M; Tominaga, Y; Yang, J | 1 |
1 review(s) available for erlotinib hydrochloride and Chronic Kidney Diseases
| Article | Year |
|---|---|
Renal toxicity of anticancer agents targeting HER2 and EGFR.
Topics: Acute Kidney Injury; Ado-Trastuzumab Emtansine; Afatinib; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lapatinib; Maytansine; Neoplasms; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Renal Dialysis; Renal Insufficiency, Chronic; Trastuzumab | 2015 |
3 other study(ies) available for erlotinib hydrochloride and Chronic Kidney Diseases
| Article | Year |
|---|---|
Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney.
Topics: Animals; Cells, Cultured; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Fibrosis; Humans; Macrophages; Male; Nephrectomy; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Signal Transduction | 2018 |
The Role of the EGF Receptor in Sex Differences in Kidney Injury.
Topics: Age Factors; Alleles; Animals; Castration; Cell Line; ErbB Receptors; Erlotinib Hydrochloride; Female; Gain of Function Mutation; Humans; Kidney; Male; Mice; Mice, Inbred C57BL; Middle Aged; Ovariectomy; Podocytes; Protein Kinase Inhibitors; Renal Insufficiency, Chronic; RNA, Messenger; Sex Factors; Testosterone | 2019 |
EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease.
Topics: Animals; Calcitriol; Carcinoma, Squamous Cell; CCAAT-Enhancer-Binding Protein-beta; Cell Line, Tumor; Disease Models, Animal; Drug Resistance; ErbB Receptors; Erlotinib Hydrochloride; Female; Genes, Reporter; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Renal Insufficiency, Chronic; Transforming Growth Factor alpha | 2008 |